Ziprasidone Mesylate 20 Mg/ml Injection, Powder, Lyophilized, For Solution
Product Images NDC 72485-430

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ziprasidone Mesylate 20 Mg/ml (NDC 72485-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ziprasidonemesylate20mg (72485430 3)

The image displays the outer package label for Ziprasidone Mesylate for Injection, 20 mg/mL, a lyophilized powder for intramuscular injection. The label indicates it contains 10 single-dose vials, is sterile, and should be protected from light. It is labeled Rx only and manufactured by Armas Pharmaceuticals Inc., with barcodes and handling instructions visible.*

FDA Label Image

Image-1 (Image 1)

Chemical structure of Ziprasidone Mesylate depicted as a molecular diagram showing its atom connectivity, including a chlorinated indole moiety and a benzo-thiazole group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.